<?xml version="1.0" encoding="UTF-8"?>
<p>Our primary finding was a highly significant improvement in maximal isometric contraction force in the treated abductor muscles of the low‐dose group compared with the placebo group after 26 weeks (
 <italic>P</italic> = 0.007) (
 <italic>Figure</italic>
 <xref rid="jcsm12316-fig-0003" ref-type="fig">3</xref>A). This improvement was accompanied by an increased GM volume (
 <italic>P</italic> = 0.004) (
 <italic>Figure</italic>
 <xref rid="jcsm12316-fig-0004" ref-type="fig">4</xref>A) without evidence for an increase in intramuscular fat (
 <italic>Figure</italic>
 <xref rid="jcsm12316-fig-0004" ref-type="fig">4</xref>B). An enhanced contraction force was also noted on the contralateral, non‐treated side in the 150 M group vs. the placebo group without increasing volume (
 <italic>Figure</italic>
 <xref rid="jcsm12316-fig-0003" ref-type="fig">3</xref>B).
</p>
